Patient Reported Outcomes following initiation of Glucagon-like peptide-1 Receptor agonists in patients with type 2 Diabetes in a specialist endocrinology practice of the LMC diabetes registry: The PROGRESS-Diabetes study

Brown Ruth E.; Abitbol Alexander; Bajaj Harpreet S.; Goldenberg Ronald; Khandwala Hasnain; Abdel-Salam Suzan; Aronson Ronnie

首页> 外文期刊>Diabetes research and clinical practice >Patient Reported Outcomes following initiation of Glucagon-like peptide-1 Receptor agonists in patients with type 2 Diabetes in a specialist endocrinology practice of the LMC diabetes registry: The PROGRESS-Diabetes study

【24h】

Patient Reported Outcomes following initiation of Glucagon-like peptide-1 Receptor agonists in patients with type 2 Diabetes in a specialist endocrinology practice of the LMC diabetes registry: The PROGRESS-Diabetes study

机译：患者报告在LMC糖尿病注册表的2型糖尿病患者中启动胰高血糖素肽-1受体激动剂后的结果：进展 - 糖尿病研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: To compare patient-reported outcomes and clinical outcomes in patients who initiated dulaglutide or liraglutide as part of usual clinical therapy.

机译：目的：将患者报告的患者报告的结果和临床结果进行比较，该患者作为通常的临床治疗的一部分发起杜拉格利德或丽柏蛋白质的患者。

著录项

来源
《Diabetes research and clinical practice》 |2019年第2019期|共8页
作者
Brown Ruth E.; Abitbol Alexander; Bajaj Harpreet S.; Goldenberg Ronald; Khandwala Hasnain; Abdel-Salam Suzan; Aronson Ronnie;
展开▼
作者单位

LMC Diabet &

Endocrinol 1929 Bayview Ave Toronto ON Canada;

LMC Diabet &

Endocrinol 1929 Bayview Ave Toronto ON Canada;

LMC Diabet &

Endocrinol 1929 Bayview Ave Toronto ON Canada;

LMC Diabet &

Endocrinol 1929 Bayview Ave Toronto ON Canada;

LMC Diabet &

Endocrinol 1929 Bayview Ave Toronto ON Canada;

LMC Diabet &

Endocrinol 1929 Bayview Ave Toronto ON Canada;

LMC Diabet &

Endocrinol 1929 Bayview Ave Toronto ON Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
Type 2 diabetes; Patient reported outcomes; Dulaglutide; Liraglutid; Registry analysis;

机译：2型糖尿病;患者报告结果;杜拉格利德;Liraglutid;注册表分析;

相似文献

外文文献
中文文献
专利

1. Patient Reported Outcomes following initiation of Glucagon-like peptide-1 Receptor agonists in patients with type 2 Diabetes in a specialist endocrinology practice of the LMC diabetes registry: The PROGRESS-Diabetes study [J] . Brown Ruth E., Abitbol Alexander, Bajaj Harpreet S., Diabetes research and clinical practice . 2019,第期

机译：患者报告在LMC糖尿病注册表的2型糖尿病患者中启动胰高血糖素肽-1受体激动剂后的结果：进展 - 糖尿病研究
2. Quality goal attainment and maintenance in patients with type II diabetes mellitus initiated on canagliflozin or a glucagon-like peptide-1 receptor agonist in an actual practice setting [J] . Wysham Carol H., Pilon Dominic, Ingham Mike, Current medical research and opinion . 2018,第6期

机译：II型糖尿病患者的质量目标达到和维护在实际实践环境中发起羊毛三唑或胰高葡聚糖样肽-1受体激动剂
3. Adherence to NICE guidance on glucagon-like peptide-1 receptor agonists among patients with type 2 diabetes mellitus: an evaluation using the Clinical Practice Research Datalink [J] . Jameson Kevin, DOca Kalpana, Leigh Paul, Current medical research and opinion . 2016,第1期

机译：遵守2型糖尿病患者胰高血糖素样肽-1受体激动剂的NICE指南：使用临床实践研究数据链进行的评估
4. Development of a Patient-Specific Model for Patients with Diabetes Type I Using Meal and Exercise Guidelines from Modern Schools of Diabetes [C] . Ghenadie Usic E-Health and Bioengineering Conference . 2020

机译：糖尿病患者的患者特异性模型，我使用膳食和糖尿病现代学派的锻炼指南
5. Glucagon-like peptide-1 delivery for treatment of type 2 diabetes. [D] . Choi, Suna. 2005

机译：胰高血糖素样肽1递送用于治疗2型糖尿病。
6. The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study [O] . Sanjoy K Paul, Kerenaftali Klein, David Maggs, 2015

机译：胰高血糖素样肽-1受体激动剂艾塞那肽或胰岛素治疗与2型糖尿病患者心血管结局的关系：一项回顾性观察研究
7. The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study [O] . Sanjoy K Paul, Kerenaftali Klein, David Maggs, 2015

机译：胰高血糖素样肽-1受体激动剂艾塞那肽或胰岛素治疗与2型糖尿病患者心血管结局的关系：一项回顾性观察研究

Patient Reported Outcomes following initiation of Glucagon-like peptide-1 Receptor agonists in patients with type 2 Diabetes in a specialist endocrinology practice of the LMC diabetes registry: The PROGRESS-Diabetes study

摘要

著录项

相似文献

相关主题

期刊订阅